Literature DB >> 11298079

Central precocious puberty: clinical and laboratory features.

W Chemaitilly1, C Trivin, L Adan, V Gall, C Sainte-Rose, R Brauner.   

Abstract

OBJECTIVE: To determine whether the initial presentation of patients with central precocious puberty (CPP) varies according to the aetiology, whether this permits the differentiation between idiopathic and organic forms, and whether the body mass index (BMI) and plasma leptin concentrations are linked to gonadotrophin secretion.
DESIGN: The clinical and laboratory features of 256 patients (26 boys and 230 girls) with CPP were studied separately in boys and girls. We compared patients with idiopathic CPP (seven boys and 186 girls) to those with organic CPP, whose pubertal development revealed a central nervous system (CNS) lesion (five boys and 11 girls), and to patients with organic CPP associated with a previously treated CNS lesion (14 boys and 33 girls).
RESULTS: Boys with organic CPP, having revealed or treated CNS lesions, started their puberty earlier (3.0 +/- 1.0 years and 6.7 +/- 0.5 years) than boys with idiopathic CPP (8.5 +/- 0.2 years, P < 0.01 and < 0.05). Boys with organic CPP associated with a treated CNS lesion had lower luteinizing hormone (LH)/follicle stimulating hormone (FSH) peaks ratio after stimulation with gonadotrophin releasing hormone (GnRH) (1.6 +/- 0.5) than did boys with idiopathic CPP (2.2 +/- 0.3, P < 0.05). Girls with organic CPP revealing a CNS lesion started their puberty earlier (3.6 +/- 0.9 years) than girls with idiopathic CPP (6.6 +/- 0.1 years, P < 0.0 l) and had higher LH (P < 0.01) and FSH peaks (< 0.05). Girls with organic CPP associated with a treated CNS lesion had higher BMI (1.8 +/- 0.2 z-score) than did girls with idiopathic CPP (1.3 +/- 0.1 zs, P < 0.05), higher leptin concentrations (11.7 +/- 1.8 microg/l vs. 7.7 +/- 0.5 microg/l, P < 0.0 l), LH peak (P < 0.01), FSH peak (P < 0.05) and LH/FSH peaks ratio (1 +/- 0.1 vs. 0.8 +/- 0.1, P < 0.05). Only 12.4% of the girls with idiopathic CPP had BMI-zs < 0, and their plasma leptins were positively correlated with BMI (P < 0.0001).
CONCLUSIONS: The features of central precocious puberty vary according to the aetiology, but it is impossible to exclude a central nervous system lesion in a given patient with central precocious puberty without performing central nervous system imaging. This imaging remains necessary in all cases of central precocious puberty. Most of the girls with idiopathic central precocious puberty had increased BMI, but we found no correlation between plasma leptin concentrations and gonadotrophin secretion.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11298079     DOI: 10.1046/j.1365-2265.2001.01229.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  22 in total

1.  Paediatric endocrinology: Treatment of girls with central precocious puberty.

Authors:  Raja Brauner
Journal:  Nat Rev Endocrinol       Date:  2015-04-28       Impact factor: 43.330

2.  Central precocious puberty following the diagnosis and treatment of paediatric cancer and central nervous system tumours: presentation and long-term outcomes.

Authors:  Wassim Chemaitilly; Thomas E Merchant; Zhenghong Li; Nicole Barnes; Gregory T Armstrong; Kirsten K Ness; Ching-Hon Pui; Larry E Kun; Leslie L Robison; Melissa M Hudson; Charles A Sklar; Amar Gajjar
Journal:  Clin Endocrinol (Oxf)       Date:  2015-11-16       Impact factor: 3.478

3.  Granular cell tumor of the neurohypophysis: report of a case with unusual age presentation.

Authors:  Paulo R Benites Filho; Daniele Sakamoto; Tiago Noguchi Machuca; Maria José Serapião; Leo Ditzel; Luiz F Bleggi Torres
Journal:  Virchows Arch       Date:  2005-08-18       Impact factor: 4.064

4.  Cranial MRI scans are indicated in all girls with central precocious puberty.

Authors:  S M Ng; Y Kumar; D Cody; C S Smith; M Didi
Journal:  Arch Dis Child       Date:  2003-05       Impact factor: 3.791

Review 5.  Sexual precocity and its treatment.

Authors:  DeAnna B Brown; Lindsey A Loomba-Albrecht; Andrew A Bremer
Journal:  World J Pediatr       Date:  2013-05-16       Impact factor: 2.764

6.  A unique case of combined pituitary hormone deficiency caused by a PROP1 gene mutation (R120C) associated with normal height and absent puberty.

Authors:  Armando Arroyo; Flavia Pernasetti; Vyacheslav V Vasilyev; Paula Amato; Samuel S C Yen; Pamela L Mellon
Journal:  Clin Endocrinol (Oxf)       Date:  2002-08       Impact factor: 3.478

7.  Causes and types of precocious puberty in north-west iran.

Authors:  Siamak Shiva; Afshin Fayyazi; Armen Melikian; Shadi Shiva
Journal:  Iran J Pediatr       Date:  2012-12       Impact factor: 0.364

8.  Pathological and incidental findings on brain MRI in a single-center study of 229 consecutive girls with early or precocious puberty.

Authors:  Signe Sloth Mogensen; Lise Aksglaede; Annette Mouritsen; Kaspar Sørensen; Katharina M Main; Peter Gideon; Anders Juul
Journal:  PLoS One       Date:  2012-01-12       Impact factor: 3.240

9.  Findings of Brain Magnetic Resonance Imaging in Girls with Central Precocious Puberty Compared with Girls with Chronic or Recurrent Headache.

Authors:  Shin-Hee Kim; Moon Bae Ahn; Won Kyoung Cho; Kyoung Soon Cho; Min Ho Jung; Byung-Kyu Suh
Journal:  J Clin Med       Date:  2021-05-19       Impact factor: 4.241

10.  Idiopathic central precocious puberty in girls: presentation factors.

Authors:  Géraldine Prété; Ana-Claudia Couto-Silva; Christine Trivin; Raja Brauner
Journal:  BMC Pediatr       Date:  2008-07-04       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.